PT  - JOURNAL ARTICLE
AU  - Italo Costanzo
TI  - Workplace sexual harassment in sexual and reproductive services: a preliminary cross-sectional study
AID  - 10.1101/2021.02.08.21251375
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.02.08.21251375
4099  - http://medrxiv.org/content/early/2021/02/11/2021.02.08.21251375.short
4100  - http://medrxiv.org/content/early/2021/02/11/2021.02.08.21251375.full
AB  - INTRODUCTION Sexual harassment at the workplace in health care is most prevalent in Anglo regions, although is an emerging problem globally. No research has yet focused on the prevalence of the phenomenon within the area of sexual and reproductive health care in Anglo regions. The aim of this study is therefore to measure the prevalence of sexual harassment in sexual and reproductive health care setting and compare it with other clinical areas.METHOD A web survey to health care workers of various NHS Trusts in the United Kingdom was carried out and a cross-sectional study was conducted to measure observed counts, expected frequencies and prevalence from a total of 90 questionnaires received.RESULTS The prevalence of workplace sexual harassment within the sexual and reproductive health services is lower compared to other clinical areas.CONCLUSIONS Working in sexual and reproductive services could be a protective factor for workplace sexual harassment, therefore this study originates a new line of research aiming to identify the protective factors against sexual harassment at the workplace in sexual and reproductive health and the ways they could be used to protect every health care worker from sexual harassment in the workplace.KEY POINTS The prevalence of workplace sexual harassment in sexual and reproductive health services is lower compared to other clinical areas.Working in sexual and reproductive services could be a protective factor for workplace sexual harassment.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding received. This study did not receive any specific grant from funding agencies in the public, commercial or not-for-profit sectors.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Approval from the ethics committee of Cambridgeshire Community Services NHS Trusts was requested and obtained.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo extra data available.